Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,180.40
-5.10 (-0.23%)
At close: Dec 9, 2025
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 902.08 billion as of December 9, 2025. Its market cap has decreased by -12.54% in one year.
Market Cap
902.08B
Enterprise Value
953.21B
Revenue
135.46B
Ranking
n/a
PE Ratio
51.34
Stock Price
2,180.40
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 902.08B, an increase of 58.33%. That is a compound annual growth rate of 19.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 902.08B | -24.09% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.33T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 930.36B |
| Aurobindo Pharma | 707.18B |
| Alkem Laboratories | 678.59B |
| Fortis Healthcare | 670.82B |